Target
Mitogen-activated protein kinase 1
Ligand
BDBM50094465
Substrate
n/a
Meas. Tech.
ChEMBL_1824543 (CHEMBL4324307)
Kd
10.0±n/a nM
Citation
 Ward, RAAnderton, MJBethel, PBreed, JCook, CDavies, EJDobson, ADong, ZFairley, GFarrington, PFeron, LFlemington, VGibbons, FDGraham, MAGreenwood, RHanson, LHopcroft, PHowells, RHudson, JJames, MJones, CDJones, CRLi, YLamont, SLewis, RLindsay, NMcCabe, JMcGuire, TRawlins, PRoberts, KSandin, LSimpson, ISwallow, STang, JTomkinson, GTonge, MWang, ZZhai, B Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC). J Med Chem 62:11004-11018 (2019) [PubMed]  Article 
Target
Name:
Mitogen-activated protein kinase 1
Synonyms:
ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK
Type:
Ser/Thr Protein Kinase
Mol. Mass.:
41392.76
Organism:
Homo sapiens (Human)
Description:
P28482
Residue:
360
Sequence:
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
  
Inhibitor
Name:
BDBM50094465
Synonyms:
CHEMBL3590106 | US10525036, Example BVD-523 | US10934304, Example BVD-523
Type:
Small organic molecule
Emp. Form.:
C21H22Cl2N4O2
Mol. Mass.:
433.331
SMILES:
CC(C)Nc1cc(-c2c[nH]c(c2)C(=O)N[C@H](CO)c2cccc(Cl)c2)c(Cl)cn1 |r|
Structure:
Search PDB for entries with ligand similarity: